Glow Protocol (GLOW) record · updated 20h ago

Skin & aestheticsHealing & recoveryGrade C · preclinicalResearch use only

All 1 studies Jump to the evidence Compare

What is Glow Protocol (GLOW) used for?

Glow Protocol (GLOW) is a multi-peptide skin rejuvenation complex combining regenerative and pigment-modulating peptides studied for photoaging, dullness, and skin barrier support.

Primarily researched for · Skin & aesthetics

Development stage

where Glow Protocol (GLOW) sits between preclinical work and regulatory approval

1Current
Preclinical
Animal / in-vitro work
2Not reached
Phase 1
Safety in humans
3Not reached
Phase 2
Efficacy signal
4Not reached
Phase 3
Confirmatory trials
5Not reached
Approved
Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus. It describes the research record, not a recommendation.

Identity

NameGlow Protocol (GLOW)

Chain length—

Molecular weight—

Formula—

Structure type—

ClassAesthetic

Research levelLimited Research

Discovered byCurated master list · 2026

Pharmacology

Mechanism—

Route—

Half-life—

Time to peak—

Duration—

Extraction confidence—

Effect profile · 0–5

These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Jul 29, 2026. How this works →

Research stats

Total studies1

Human / animal / cellular0 / 1 / 0

Highest trial phase—

Years covered2026

Latest study28d ago

Publication history

20262026

Research funding

12 NIH projects · $5.1M awarded · through FY2020

Public grants naming this compound. Funding is interest, not evidence.

Safety signals

FAERS reportsnone recorded

Serious AEs in animal work—

Community reports—

Positive —Neutral —Negative —

Records

ChEMBL ClinicalTrials.gov DrugBank Google Scholar PubChem PubMed · 1 Semantic Scholar UniProt

Study register

1 rowOpen in the library →

Study	Type	Year	Summary depth
PRX5 as a critical driver of colorectal cancer stemness and tumorigenicity. Finding2.5-fold greater tumor volume by day 19, n=Not reported in abstract.	Animal	2026	Full text read0.70

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching Glow Protocol (GLOW) will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much Glow Protocol (GLOW) is discussed should be drawn from it.